$1.69
0.053.05%
At close: -
$1.61
-0.08-4.73%
After Hours: 4:09 PM EDT
Comments
Loading...
Mangoceuticals Analyst Ratings and Price Targets | NASDAQ:MGRX | Benzinga
Mangoceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Mangoceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for Mangoceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Mangoceuticals (MGRX) stock?
There is no price target for Mangoceuticals
What is the most recent analyst rating for Mangoceuticals (MGRX)?
There is no analyst for Mangoceuticals
When was the last upgrade for Mangoceuticals (MGRX)?
There is no last upgrade for Mangoceuticals
When was the last downgrade for Mangoceuticals (MGRX)?
There is no last downgrade for Mangoceuticals.
When is the next analyst rating going to be posted or updated for Mangoceuticals (MGRX)?
There is no next analyst rating for Mangoceuticals.
Is the Analyst Rating Mangoceuticals (MGRX) correct?
There is no next analyst rating for Mangoceuticals.
Browse analyst ratings and price targets on all stocks.
